Oh man, **UnitedHealthcare** stock. Year to date, shares are down 50%, wiping out roughly \$254 per share in market value. Let’s unpack what’s driving the slide, explore the key financials, and see if this pullback masks a buying opportunity.

A little over a month ago, I covered Hims & Hers stock and rated it a buy on August 5, 2025. Since then, the share price has climbed nearly 29%, prompting a fresh look at this telehealth and wellness company’s valuation.

Hello everyone, I’m Kaneka. Today, I’ll be analyzing **Colgate Palmolive Limited**. We’ll look at both the **fundamental analysis** and the **technical chart patterns** of the stock.

It’s not exactly difficult these days to find a company paying a 3–4% dividend yield. Plenty of names come to mind right away. But Extra Space Storage (NYSE: EXR) stands out because it doesn’t just pay a dividend—it has a long track record of consistent growth.

Today, we’re diving into Lucid’s latest trading session, breaking down the numbers that moved the needle and outlining everything you need to know.